Tag: 7

BALA CYNWYD, Pa., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Law office of Brodsky & Smith announces that it is investigating potential claims against the Board of Directors of Performant Healthcare, Inc. (“Performant Healthcare” or the “Company”) (Nasdaq - PHLT) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to Machinify. Under the terms of the transaction, Machinify will acquire all outstanding shares of Performant Healthcare for $7.75 per share in cash.

Basel, 01 August 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today new, five-year efficacy, safety and durability data from the Phase III Portal study, a long-term extension of the Phase III Archway study, of Susvimo® (ranibizumab injection) for the treatment of people with nAMD.¹ Results show that Susvimo’s immediate and predictable durability was sustained over five years, with approximately 95% of people receiving treatment every six months requiring no supplemental treatment before each refill. The data were presented at the American Society of Retina Specialists (ASRS) 2025 Annual Meeting in Long Beach, California, United States.

LES RÉSULTATS DU TEST DE RÉSISTANCE EUROPÉEN 2025 CONFIRMENT LA FORTE CAPACITÉ D’ABSORPTION DES CHOCS ET LA RESILIENCE STRUCTURELLE DE BNP PARIBAS

BONDUELLE